Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106 USD | -1.21% | -1.51% | -3.72% |
04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.72% | 184B | |
-2.60% | 107B | |
-3.79% | 67.78B | |
+2.66% | 50.66B | |
+16.39% | 47.64B | |
+4.60% | 41.12B | |
+1.38% | 26.3B | |
+1.52% | 26.04B | |
-1.17% | 24.71B | |
+15.06% | 25.4B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Evercore ISI Adjusts Abbott Laboratories PT to $145 From $136, Maintains Outperform Rating